Alan B. Lancz & Associates’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $558K | Hold |
2,025
| – | – | 0.56% | 43 |
|
|
2025
Q1 | $537K | Hold |
2,025
| – | – | 0.57% | 46 |
|
|
2024
Q4 | $470K | Sell |
2,025
-600
| -23% | -$139K | 0.48% | 52 |
|
|
2024
Q3 | $579K | Hold |
2,625
| – | – | 0.53% | 47 |
|
|
2024
Q2 | $516K | Buy |
+2,625
| New | +$516K | 0.51% | 45 |
|
|
2023
Q4 | $553K | Sell |
2,625
-100
| -4% | -$21.1K | 0.58% | 39 |
|
|
2023
Q3 | $546K | Sell |
2,725
-100
| -4% | -$20K | 0.62% | 40 |
|
|
2023
Q2 | $523K | Hold |
2,825
| – | – | 0.56% | 48 |
|
|
2023
Q1 | $541K | Hold |
2,825
| – | – | 0.56% | 46 |
|
|
2022
Q4 | $496K | Hold |
2,825
| – | – | 0.5% | 56 |
|
|
2022
Q3 | $500K | Hold |
2,825
| – | – | 0.59% | 43 |
|
|
2022
Q2 | $564K | Sell |
2,825
-100
| -3% | -$20K | 0.56% | 42 |
|
|
2022
Q1 | $696K | Hold |
2,925
| – | – | 0.62% | 38 |
|
|
2021
Q4 | $668K | Buy |
+2,925
| New | +$668K | 0.58% | 46 |
|